George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

19 Jan 2010 07:00

RNS Number : 7399F
Plethora Solutions Holdings PLC
19 January 2010
 



19 January 2010

Plethora Solutions Holdings plc

("Plethora" or the "Company")

Pre-Close Trading Update

Plethora is pleased to announce its trading update following the completion of the financial year ended 31 December 2009. During the year Plethora completed a successful restructuring which included a substantial reduction in borrowings and secured longer-term licensing revenues. In the second half of the year the Company established a new marketing and distribution subsidiary, The Urology Company Limited, to leverage the Group's expertise in the urology market in the UK.

The Company anticipates announcing results for the year ended 31 December 2009 in March 2010. These results are expected to be in line with analyst expectations and are expected to show the following key features;

As a result of the licensing and collaboration agreement with Sciele Pharma, Inc. for the worldwide rights to PSD502, Plethora's treatment for premature ejaculation, the Company expects to announce total revenues in excess of £17.5 million for the year. 

Following the maiden profit recorded in the 2009 interim results, the Company anticipates recording a profit for the full year.

As a result of the financial restructuring announced in May the Group's borrowings have been reduced substantially:

All liabilities to Paul Capital Healthcare and ETV Capital S.A. have been repaid or expunged.

At the year end total borrowings comprised £2.2 million in three tranches of convertible loan notes which have been brought onto common terms and mature on 31 December 2012. 

A continued focus on strict cost control and reduction. 
Following completion of a placing to raise £1.56 million, cash at 31 December 2009 is in excess of £1.4 million.

Dr Steven Powell, CEO, said, "Throughout 2009 Plethora has worked to reduce gearing and put commercial structures in place to ensure that embedded value in the development pipeline accrues to equity shareholders. The establishment of The Urology Company subsidiary is designed to exploit our know-how and expertise in urology and, together with future royalties from our development programmes, create a valuable, growing and sustainably profitable business in the medium term."

-ends-

Enquiries:

Plethora Solutions

Steven Powell/Ronald Openshaw

Tel : +44(0) 20 3077 5400

FinnCap

Geoff Nash/Marc Young

Tel : +44(0) 20 7600 1658

Hansard Communications

John Bick/Kirsty Corcoran

Tel: +44(0) 20 7245 1100

Tel: +44(0) 7872 061007

About Plethora:

Plethora is focused on the development and marketing of products for the treatment of urological disorders. The Company has products in clinical development for the treatment of overactive bladder (PSD506), stress urinary incontinence (PSD503), interstitial cystitis (PSD597), gynaecological pain (PSD508), erectile dysfunction (PSD510) and premature ejaculation (PSD502). Plethora's subsidiary, The Urology Company Limited, was established in 2009 to market and distribute a range of therapeutic products for the treatment of urology, andrology and obstetric conditions. The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE.L).

Further information is available at www.plethorasolutions.co.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKFDNABKDBDD
Date   Source Headline
9th Mar 20168:15 amRNSScheme becomes Effective
8th Mar 20164:44 pmRNSCourt Sanction of Scheme - Replacement
8th Mar 20163:12 pmRNSScheme becomes Effective
8th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
8th Mar 20167:30 amRNSSuspension - Plethora Solutions Holdings Plc
7th Mar 20161:36 pmRNSSuspension of trading of Shares
7th Mar 20169:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
4th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
3rd Mar 20165:25 pmRNSR&D Tax Credit Receipt and Director Dealing
3rd Mar 201611:47 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
2nd Mar 201612:00 pmRNSResult of Shareholder and Court Meetings
2nd Mar 201611:20 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
1st Mar 201610:23 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
29th Feb 201611:14 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
26th Feb 20167:34 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
25th Feb 20169:33 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
24th Feb 20169:00 amRNSLetter of Intent Signed
24th Feb 20168:50 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
23rd Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
22nd Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
19th Feb 20167:50 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
18th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
17th Feb 201611:30 amRNSDisposal of Shares in Endeavour Mining Corporation
17th Feb 20168:29 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
16th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
15th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
12th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
11th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
11th Feb 20168:28 amRNSExpected timetable for suspension and de-listing
10th Feb 201611:35 amBUSForm 8.3 - Plethora Solutions Holdings Plc
10th Feb 20169:30 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
9th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20168:11 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
5th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions Hldgs PLC
4th Feb 20169:00 amRNSPosting Scheme Document & Plethora Trading Update
3rd Feb 20169:29 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
2nd Feb 20162:52 pmRNSForm 8.3 - Plethora Solutions Holdings Plc
2nd Feb 20168:11 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
1st Feb 20168:34 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
29th Jan 20168:34 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
28th Jan 20169:06 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
27th Jan 20169:01 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
26th Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
26th Jan 20169:00 amRNSTrading Update
25th Jan 20169:24 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
25th Jan 20169:00 amRNSOffer Update
22nd Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions Hldgs PLC
21st Jan 20169:02 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
20th Jan 20169:00 amRNSForm 8 (OPD) (Plethora Solutions) - Replacement
20th Jan 20168:30 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.